Re-evaluating the grading of established commercialized meningioma cell line

Neurosurg Rev. 2024 Jul 16;47(1):335. doi: 10.1007/s10143-024-02571-1.

Authors

Wassim Khalil¹, Alexandre Perani², Orianne Besse³, Karine Durand^{2

3}, Henri Salle^{4

3}

Affiliations

¹ Neurosurgery department, Limoges University Medical Center, Limoges, France. [email protected].
² Pathology and molecular biology department, Limoges University Medical Center, Limoges, France.
³ CAPTuR, INSERM Limoges University, Limoges, France.
⁴ Neurosurgery department, Limoges University Medical Center, Limoges, France.

PMID: 39009954
DOI: 10.1007/s10143-024-02571-1

No abstract available

Publication types

Letter

MeSH terms

Cell Line, Tumor
Humans
Meningeal Neoplasms* / pathology
Meningioma* / pathology
Neoplasm Grading / methods